Evolus, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on February 12, 2018, for Evolus, Inc., a Delaware corporation. The filing primarily documents the closing of the Company's Initial Public Offering (IPO) and associated corporate governance changes.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to the capital raise:
- Shares Sold: 5,000,000 shares of common stock.
- Offering Price: $12.00 per share (before underwriting discounts and commissions).
- Over-Allotment Option: Underwriters granted an option to purchase an additional 750,000 shares at the IPO price, exercisable within 30 days. This option has not yet been exercised.
Material Changes
The primary material change is the transition from a private to a public company via the IPO closing on February 12, 2018. Additionally, the Company filed an Amended and Restated Certificate of Incorporation and adopted Amended and Restated Bylaws effective February 9, 2018, in connection with the offering.
Management Commentary, Governance, and Risks
Board Appointments: Effective upon the IPO closing, David N. Gill was appointed to the Board of Directors. He serves as a member of the Compensation Committee and Chairman of the Audit Committee. The filing states Mr. Gill has no material interests or undisclosed arrangements requiring disclosure.
Corporate Governance: The Restated Certificate and Bylaws are incorporated by reference from the Registration Statement on Form S-1.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard disclosure that the over-allotment option remains unexercised.
Key Facts for Investor Verification
- Verify the final gross proceeds from the IPO after deducting underwriting discounts and commissions.
- Confirm whether the underwriters have exercised the 750,000 share over-allotment option within the 30-day window.
- Review the full text of the Amended and Restated Certificate of Incorporation and Bylaws (Exhibits 3.1 and 3.2) for specific provisions regarding capital stock and governance.
- Consult the Registration Statement on Form S-1 (File No. 333-222478) for detailed biographical information on David N. Gill and the Company's financial history.